NDC 70771-1901 – Dasatinib
Dasatinib 20 mg/1 · Tablet · Oral
Product NDC70771-1901
Product details
- Brand name
- Dasatinib
- Generic name
- Dasatinib
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA218719
- Marketed since
- March 3, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Dasatinib 20 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70771-1901-6 | 60 TABLET in 1 BOTTLE (70771-1901-6) | Mar 3, 2025 |
Other Dasatinib products
- 59651-542 Dasatinib 20 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-543 Dasatinib 50 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-544 Dasatinib 70 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-545 Dasatinib 80 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-546 Dasatinib 100 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-547 Dasatinib 140 mg/1 · Tablet · Aurobindo Pharma Limited
- 70748-211 Dasatinib 80 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-213 Dasatinib 140 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-208 Dasatinib 20 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-212 Dasatinib 100 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-209 Dasatinib 50 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.
- 70748-210 Dasatinib 70 mg/1 · Tablet · Lupin Pharmaceuticals, Inc.